ASML's 30% Production Surge Meets the One Risk It Cannot Manufacture Its Way Out Of
Published on 07/19/2026 at 07:22 | Redaktion boerse-global.de
ASML has done everything a chip-equipment giant can do to reassure markets: raised its revenue forecast twice in one year, laid out aggressive capacity expansion plans, and pointed to rock-solid demand from AI-driven customers. Yet the stock closed Friday at €1,528.00, down 2.51% on the day and 6.29% over the past month. The contradiction is not a market failure to appreciate the numbers. It is the growing realization that a single piece of unfinished US legislation could cut through the growth story like a knife.
The source of that anxiety is the MATCH Act, a proposed US export control bill that would tighten restrictions on sales of advanced chipmaking equipment to China. It has not passed. It remains a draft in the political process, and the Netherlands has lodged diplomatic objections. But the mere fact of its existence is now the dominant variable in how investors price ASML—more so than the company's own guidance, which is at record levels.
A €45 Billion Ceiling That Comes With a China Cap
On the operational side, the case for owning ASML has rarely been stronger. The company raised its 2026 revenue target to a range of €43–€45 billion, up from an earlier €36–€40 billion, and expects gross margins of 54%–56%. To deliver on those numbers, ASML is planning to boost production of its EUV and immersion DUV machines by 30% annually over the next two years.
CEO Christophe Fouquet said customers are accelerating their capacity plans, translating into firm orders across the full product portfolio and giving management higher visibility into long-term demand. Specifically, ASML expects to deliver about 65 low-NA EUV systems in 2026—a 45% jump in its EUV business—along with 130 immersion DUV units. In a sign that the technology transition is accelerating, Intel Foundry has already produced a high-volume logic product using High-NA EUV lithography, the first time that has happened at scale.
Should investors sell immediately? Or is it worth buying Asml?
Memory customers are providing a second growth pillar. Fouquet forecasts a 75% revenue surge from that segment in 2026, fueled by capacity expansions for High-Bandwidth Memory and DDR chips. The stock still trades 30.53% above its 200-day moving average, suggesting the long-term trend remains intact despite the recent pullback.
The China Fracture That No Production Boost Can Fix
Here is the rub: China accounts for roughly 20% of the 2026 revenue baked into that €45 billion outlook, and that number is already under pressure. ASML’s China revenue share dropped from 19% in the first quarter to 14% in the second, a decline that predates any new legislation. The MATCH Act would target the DUV machines that ASML can still legally sell to Chinese chipmakers—machines that represent the vast majority of that China exposure.
Javier Correonero of Morningstar notes that ASML is trading at a forward P/E of around 50, a level reminiscent of the pandemic-era euphoria. His own fair-value estimate implies a multiple of 35 to 40. With the stock just 1.53% above its 50-day average of €1,504.90, the short-term momentum has stalled. The 14-day RSI sits at a neutral 47.5, and the annualized 30-day volatility is a high 60.59%. That leaves the stock primed for sharp moves in either direction as soon as new headlines emerge from Washington.
Two Scenarios, One Diverging Path
What happens next depends on whether the debate in the US Congress gathers pace or fades. If the MATCH Act stalls or is watered down, the stock could defend its level near the 50-day average and eventually push back toward the 52-week high of €1,748.00. The growth narrative is real: ASML's order book runs deep into 2028, and the company's ability to turn capacity expansion into delivered, paid machines is the bull case's strongest argument.
If the legislation gains traction and pushes the China share materially below the 20% baked into guidance, the valuation premium becomes harder to justify. A retreat to the 100-day average near €1,356.00 would not be out of the question.
Asml at a turning point? This analysis reveals what investors need to know now.
The next concrete milestone is August 5, 2026, when ASML pays an interim dividend of €1.88 per share—a signal of management's confidence in the company's cash position. The bigger date is the Capital Markets Day in June 2027, when today's capacity plans must prove they have turned into fixed, multi-year order books.
For now, the real lever on ASML's share price is not in any factory in Veldhoven. It is in the wording of a legislative text that has not yet become law—and may never become law. But the market is already pricing the risk as if it will, and that tension shows no sign of easing.
Ad
Asml Stock: New Analysis - 19 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
